• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Acuson moves NHTI to 128XP line

Article

Acuson of Mountain View, CA, has migrated its Native Tissue Harmonic Imaging technique to its 128XP ultrasound scanners. NTHI was first introduced on the super-premium Sequoia system last year. Since then it has been moved to other systems in the

Acuson of Mountain View, CA, has migrated its Native Tissue Harmonic Imaging technique to its 128XP ultrasound scanners. NTHI was first introduced on the super-premium Sequoia system last year. Since then it has been moved to other systems in the company’s product line, such as Aspen and 128XP. The upgrade will begin shipping next year and will be available to all 128XP users.

In other Acuson news, the company landed a preferred provider contract with Columbia/HCA, which named Acuson as one of three ultrasound providers to the hospital chain. The deal extends an existing relationship between Acuson and Columbia. Acuson estimated that the agreement will be worth about $15 million over the next two years.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.